United States
Valeant plans to raise offer for Salix close to $170/share: source
Valeant Pharmaceuticals International Inc (VRX.TO) plans to raise its bid for Salix Pharmaceuticals Ltd (SLXP.O) close to $170 per share, a person familiar with matter told Reuters.
Coke CEO's declined bonus not enough for pay critic Winters
A decision by Coca-Cola Co's chief executive to decline his 2014 bonus did not go far enough, a well-known pay critic said Friday, indicating the company could face more scrutiny of its compensation ahead of its shareholder meeting this spring.
Investors in 'patient panic' over Fed language
Forget the 2013 "taper tantrum." U.S. stock markets are in the midst of a "'patient' panic" ahead of Wednesday's Federal Reserve statement, when many investors expect a change in the Fed's language that would send the clearest signal yet that a rate hike is coming soon.
Wall St. resumes fall as dollar hits 12-year high
U.S. stocks fell on Friday and the Dow and S&P 500 registered a third week of losses as the dollar resumed its climb, adding to worries about its impact on U.S. multinationals' earnings.